Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Effect of deferasirox and deferoxamine treatment on hematopoietic stem cells gene expression


ABSTRACT: To investigate new molecular pathways affected by deferasirox or deferoxamine able to explain hematopoiesis restoration

ORGANISM(S): Homo sapiens

SUBMITTER: Vittorio Simeon 

PROVIDER: E-MTAB-6658 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Deferasirox drives ROS-mediated differentiation and induces interferon-stimulated gene expression in human healthy haematopoietic stem/progenitor cells and in leukemia cells.

Tataranni Tiziana T   Mazzoccoli Carmela C   Agriesti Francesca F   De Luca Luciana L   Laurenzana Ilaria I   Simeon Vittorio V   Ruggieri Vitalba V   Pacelli Consiglia C   Della Sala Gerardo G   Musto Pellegrino P   Capitanio Nazzareno N   Piccoli Claudia C  

Stem cell research & therapy 20190613 1


<h4>Background</h4>Administration of the iron chelator deferasirox (DFX) in transfusion-dependent patients occasionally results in haematopoiesis recovery by a mechanism remaining elusive. This study aimed to investigate at a molecular level a general mechanism underlying DFX beneficial effects on haematopoiesis, both in healthy and pathological conditions.<h4>Methods</h4>Human healthy haematopoietic stem/progenitor cells (HS/PCs) and three leukemia cell lines were treated with DFX. N-Acetyl cys  ...[more]

Similar Datasets

2017-05-09 | E-MTAB-4540 | biostudies-arrayexpress
2016-10-03 | E-MTAB-4536 | biostudies-arrayexpress
2016-05-25 | E-MTAB-3799 | biostudies-arrayexpress
2014-11-15 | E-MTAB-2500 | biostudies-arrayexpress
2017-06-30 | E-MTAB-3584 | biostudies-arrayexpress
2016-05-06 | E-MTAB-3796 | biostudies-arrayexpress
2019-12-01 | E-MTAB-6152 | biostudies-arrayexpress
2015-10-14 | E-MTAB-3576 | biostudies-arrayexpress
2020-01-20 | E-MTAB-6105 | biostudies-arrayexpress
2014-11-13 | E-MTAB-2085 | biostudies-arrayexpress